PBLCX
Price
$41.77
Change
-$0.73 (-1.72%)
Updated
Jun 13 closing price
Net Assets
11.03B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

PBLCX vs RGEBX

Header iconPBLCX vs RGEBX Comparison
Open Charts PBLCX vs RGEBXBanner chart's image
Principal Blue Chip C
Price$41.77
Change-$0.73 (-1.72%)
VolumeN/A
Net Assets11.03B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
PBLCX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PBLCX vs. RGEBX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBLCX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. PBLCX (11B). PBLCX (0.00) and RGEBX (0.00) have matching dividends . PBLCX was incepted earlier than RGEBX: PBLCX (12 years) vs RGEBX (11 years). PBLCX (1.69) is less costly to investors than RGEBX (1.09). RGEBX is a more actively managed with annual turnover of: 25.00 vs. PBLCX (14.70). RGEBX has a lower initial minimum investment than PBLCX: RGEBX (250) vs PBLCX (1000). PBLCX annual gain was more profitable for investors over the last year : 8.41 vs. RGEBX (7.68). PBLCX return over 5 years is better than : 55.68 vs. RGEBX (45.42).
PBLCXRGEBXPBLCX / RGEBX
Total Expense Ratio1.661.09152%
Annual Report Gross Expense Ratio1.691.09155%
Fund Existence12 years11 years-
Gain YTD4.0874.82985%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets11B306B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year8.417.68110%
Returns for 3 years66.8851.01131%
Returns for 5 years55.6845.42123%
Returns for 10 years163.7065.87249%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd